| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 122K | $3.29M | $27.05 | Sep 9, 2024 | Direct |
| Talis Biomedical Corp | Director | Stock option (right to buy) | 5.47K | Jun 9, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | Sep 9, 2024 | 1 | -$271K | 4 | Sep 9, 2024 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| TLIS | Talis Biomedical Corp | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| TLIS | Talis Biomedical Corp | May 19, 2023 | 1 | $0 | 4 | May 23, 2023 | Director |
| TLIS | Talis Biomedical Corp | May 19, 2023 | 0 | $0 | 3 | May 23, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |